<DOC>
	<DOC>NCT00814060</DOC>
	<brief_summary>This study will examine the bioavailability (the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action) of two tablet formulations of Neratinib (HKI-272) compared to the capsule formulation.</brief_summary>
	<brief_title>Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)</brief_title>
	<detailed_description />
	<criteria>Healthy male and female subjects, ages 1850.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>